Cargando…

Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis

The prognostic impact of excision repair cross-complementation group 1 (ERCC1) expression in gastric cancer (GC) has been investigated for decades, but has yielded controversial results. The aim of the present study was to provide a precise evaluation of whether the expression levels of ERCC1 are as...

Descripción completa

Detalles Bibliográficos
Autores principales:	SONG, PENG, YIN, QIN, LU, MING, FU, BO, WANG, BAOLIN, ZHAO, QINGHONG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353740/ https://www.ncbi.nlm.nih.gov/pubmed/25780441 http://dx.doi.org/10.3892/etm.2015.2284

Ejemplares similares

Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer
por: Luo, Shan-Shan, et al.
Publicado: (2018)

The prognostic value of excision repair cross-complementing Group 1 expression in nasopharyngeal cancer patients
por: Chitapanarux, Imjai, et al.
Publicado: (2020)

Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy
por: Li, Mu-Xing, et al.
Publicado: (2016)

Diagnostic and prognostic values of the mRNA expression of excision repair cross-complementation enzymes in hepatitis B virus-related hepatocellular carcinoma
por: Yang, Lu, et al.
Publicado: (2018)

Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis
por: Lv, Yalei, et al.
Publicado: (2021)

The Prognostic Value of Excision Repair Cross-Complementation Group 1 (ERCC1) in Patients with Small Cell Lung Cancer (SCLC) Receiving Platinum-Based Chemotherapy: Evidence from Meta-Analysis
por: Yang, Yanlong, et al.
Publicado: (2014)

X-Ray Repair Cross Complementing Protein 1 in Base Excision Repair
por: Hanssen-Bauer, Audun, et al.
Publicado: (2012)

Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk
por: Tsai, Chia-Wen, et al.
Publicado: (2018)

Complementation of aprataxin deficiency by base excision repair enzymes
por: Çağlayan, Melike, et al.
Publicado: (2015)

Molecular spectrum of excision repair cross-complementation group 8 gene defects in Chinese patients with Cockayne syndrome type A
por: Wang, Xiaozhu, et al.
Publicado: (2017)

Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations
por: Hubner, Richard A., et al.
Publicado: (2011)

Excision repair cross-complementing group 2 upregulation is a potential predictive biomarker for oral squamous cell carcinoma recurrence
por: Wang, Yen-Yun, et al.
Publicado: (2021)

Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer
por: Aiello, Marco Maria, et al.
Publicado: (2020)

Excision Repair Cross-Complementation Group 6 Gene Polymorphism Is Associated with the Response to FOLFIRINOX Chemotherapy in Asian Patients with Pancreatic Cancer
por: Choi, Young Hoon, et al.
Publicado: (2021)

Complementation of aprataxin deficiency by base excision repair enzymes in mitochondrial extracts
por: Çağlayan, Melike, et al.
Publicado: (2017)

Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy
por: Kim, Miso, et al.
Publicado: (2015)

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma
por: Peng, Haiying, et al.
Publicado: (2018)

Elucidating the role of excision repair cross-complement group 1 in oral epithelial dysplasia and early invasive squamous cell carcinoma: An immunohistochemical study
por: Kulkarni, Spoorti, et al.
Publicado: (2020)

Base excision repair imbalance in colorectal cancer has prognostic value and modulates response to chemotherapy
por: Leguisamo, Natalia M., et al.
Publicado: (2017)

Prognostic Value of Complement Properdin in Cancer
por: Mangogna, Alessandro, et al.
Publicado: (2021)

Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer
por: Mountzios, Giannis, et al.
Publicado: (2008)

Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer
por: Dudás, József, et al.
Publicado: (2014)

Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin
por: Rao, Devika, et al.
Publicado: (2019)

Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin-resistant cell line to oxaliplatin by inhibiting excision repair cross-complementing group 1 protein expression
por: Li, Ji-Min, et al.
Publicado: (2019)

Nucleotide excision repair: a versatile and smart toolkit: Nucleotide excision repair
por: Zhang, Xiping, et al.
Publicado: (2022)

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer
por: Matsubara, J, et al.
Publicado: (2008)

Crosstalk between mismatch repair and base excision repair in human gastric cancer
por: Simonelli, Valeria, et al.
Publicado: (2016)

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma: Erratum
Publicado: (2018)

Pan-cancer analysis of the prognostic and immunological role of Fanconi anemia complementation group E
por: Zhou, Zhixian, et al.
Publicado: (2023)

Prognostic Role of MicroRNA-497 In Cancer Patients: A Meta-analysis
por: Feng, Jiaxi, et al.
Publicado: (2018)

AB153. Down-regulated expression of excision of repair cross-complementing gene 1 reduces resistance to hydroxycamptothecine in bladder cancer
por: Liu, Yili
Publicado: (2016)

X-Ray Repair Cross-Complementing Group 1 (XRCC1) Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia: A Meta-Analysis
por: Wang, Libing, et al.
Publicado: (2012)

Prognostic significance of X-ray cross-complementing gene 1 expression in gastric cancer
por: Wang, Jian, et al.
Publicado: (2016)

Clinicopathological Characteristics and Prognostic Value of Signet Ring Cells in Gastric Carcinoma: A Meta-Analysis
por: Nie, Run-Cong, et al.
Publicado: (2017)

Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis
por: Lu, Li, et al.
Publicado: (2016)

Prognostic Value of ANXA8 in Gastric Carcinoma
por: Ma, Fangqi, et al.
Publicado: (2020)

Effects of p38MAPK-mediated excision repair cross-complementation 1 expression on prognosis of patients with non-small cell lung cancer
por: He, Dan, et al.
Publicado: (2017)

Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis
por: Gao, Yunhe, et al.
Publicado: (2016)

The prognostic value of circRNAs for gastric cancer: A systematic review and meta‐analysis
por: Chen, Hui, et al.
Publicado: (2020)

Role of Nucleotide Excision Repair in Cisplatin Resistance
por: Duan, Mingrui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dh0952pfcfsfch0e28gdhbg3hp